ARTICLE | Clinical News
Procysbi cysteamine bitartrate delayed-release capsules regulatory update
August 24, 2015 7:00 AM UTC
FDA approved an sNDA from Raptor for Procysbi cysteamine bitartrate delayed-release capsules to treat nephropathic cystinosis in patients ages 2-6. Procysbi is now indicated in patients ages >=2. The ...